Regulon

Regulon: R-1994

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
192.73259124Pr-43Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
6717 ENSG00000075142 SRI P30626
7205 ENSG00000087077 TRIP6 Q15654
8406 ENSG00000101955 SRPX P78539
760 ENSG00000104267 CA2 P00918
8985 ENSG00000106397 PLOD3 O60568
1647 ENSG00000116717 GADD45A P24522
1266 ENSG00000117519 CNN3 Q15417
2152 ENSG00000117525 F3 P13726
57134 ENSG00000117643 MAN1C1 Q9NR34
10267 ENSG00000132329 RAMP1 O60894
92579 ENSG00000141349 G6PC3 K7ENK1
8324 ENSG00000155760 FZD7 O75084
1827 ENSG00000159200 RCAN1 P53805
9263 ENSG00000164543 STK17A Q9UEE5
9122 ENSG00000168679 SLC16A4 O15374
1140 ENSG00000170175 CHRNB1 P11230
23333 ENSG00000173852 DPY19L1 Q2PZI1
1466 ENSG00000175183 CSRP2 Q16527
24147 ENSG00000179431 FJX1 Q86VR8

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
CISATRACURIUMCHRNA1Small moleculeANTAGONISTMuscle-type nicotinic acetylcholine receptor antagonist40
CISATRACURIUM BESYLATECHRNA1Small moleculeANTAGONISTMuscle-type nicotinic acetylcholine receptor antagonist40
SUXAMETHONIUMCHRNA1Small moleculeAGONISTMuscle-type nicotinic acetylcholine receptor agonist40
PRAMLINTIDERAMP1ProteinAGONISTAmylin receptor AMY1, CALCR/RAMP1 agonist40
BRINZOLAMIDECA2Small moleculeINHIBITORCarbonic anhydrase II inhibitor40
DORZOLAMIDE HYDROCHLORIDECA2Small moleculeINHIBITORCarbonic anhydrase II inhibitor40
DICHLORPHENAMIDECA4Small moleculeINHIBITORCarbonic anhydrase IV inhibitor40
MIVACURIUMCHRNA1Small moleculeANTAGONISTMuscle-type nicotinic acetylcholine receptor antagonist40
SULTHIAMECA2Small moleculeINHIBITORCarbonic anhydrase inhibitor40
DORZOLAMIDECA2Small moleculeINHIBITORCarbonic anhydrase II inhibitor40
ROCURONIUM BROMIDECHRNA1Small moleculeANTAGONISTMuscle-type nicotinic acetylcholine receptor antagonist40
ACETAZOLAMIDECA4Small moleculeINHIBITORCarbonic anhydrase XII inhibitor40
METHAZOLAMIDECA2Small moleculeINHIBITORCarbonic anhydrase II inhibitor40
MIVACURIUM CHLORIDECHRNA1Small moleculeANTAGONISTMuscle-type nicotinic acetylcholine receptor antagonist40
PRAMLINTIDE ACETATERAMP1ProteinAGONISTAmylin receptor AMY1, CALCR/RAMP1 agonist40
TISOTUMAB VEDOTINF3AntibodyBINDING AGENTCoagulation factor III binding agent40
TOPIRAMATECA4Small moleculePOSITIVE MODULATORGABA-A receptor; anion channel positive modulator40
VANTICTUMABFZD5AntibodyANTAGONISTFrizzled-1 antagonist10
ACETAZOLAMIDE SODIUMCA4Small moleculeINHIBITORCarbonic anhydrase XII inhibitor40
POLMACOXIBPTGS2Small moleculeINHIBITORCarbonic anhydrase I inhibitor30
ROCURONIUMCHRNA1Small moleculeANTAGONISTMuscle-type nicotinic acetylcholine receptor antagonist40
DAVALINTIDERAMP1ProteinAGONISTCalcitonin gene-related peptide type 1 receptor agonist20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1994

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00981TPTEdown-regulatesLHX3repressesR-1994249Drugs (22)
CMF-01481MTORdown-regulatesLHX3repressesR-1994248Drugs (22)
CMF-05460KIAA1549down-regulatesLHX3repressesR-1994244Drugs (22)
CMF-05641ITGB7down-regulatesLHX3repressesR-1994242Drugs (22)
CMF-07293NOD2down-regulatesLHX3repressesR-1994249Drugs (22)
CMF-07422THOC2down-regulatesLHX3repressesR-1994248Drugs (22)
CMF-09428ZIC4down-regulatesLHX3repressesR-1994242Drugs (22)
CMF-11878PALM2-AKAP2down-regulatesLHX3repressesR-1994245Drugs (22)
CMF-14143CD1Ddown-regulatesLHX3repressesR-1994242Drugs (22)
CMF-14204ZNF516down-regulatesLHX3repressesR-1994244Drugs (22)
CMF-14396LYPLA2P1down-regulatesLHX3repressesR-1994241Drugs (22)
CMF-15112KCNQ5down-regulatesLHX3repressesR-1994244Drugs (22)
CMF-15543TAS2R41down-regulatesLHX3repressesR-1994244Drugs (22)
CMF-15660DCHS2down-regulatesLHX3repressesR-1994245Drugs (22)
CMF-15731FN1down-regulatesLHX3repressesR-1994242Drugs (22)
CMF-16437SUSD5down-regulatesLHX3repressesR-1994247Drugs (22)
CMF-17389TBC1D8down-regulatesLHX3repressesR-1994244Drugs (22)
CMF-18477LAMA1down-regulatesLHX3repressesR-1994248Drugs (22)
CMF-19933ACTL9down-regulatesLHX3repressesR-1994245Drugs (22)
CMF-20184PARP4down-regulatesLHX3repressesR-1994241Drugs (22)
CMF-21954FAT1down-regulatesLHX3repressesR-1994244Drugs (22)
CMF-22585IDH1up-regulatesLHX3repressesR-19942421Drugs (22)
CMF-27327CHD5down-regulatesLHX3repressesR-1994246Drugs (22)
CMF-30811RYR1down-regulatesLHX3repressesR-1994246Drugs (22)